What a USP or pharmaceutical-grade claim commits a seller to

Two phrases that look alike and are not

Product pages in this market use two kinds of quality phrase. One is a grade word. The other is a pharmacopeia name.

The grade words carry no legal weight at all. Six federal documents were read end to end for this article. The definitions of drug and of official compendium, the section on adulterated drugs, the section on misbranded drugs, the whole good manufacturing practice regulation for finished pharmaceuticals, and the whole regulation on drug names. The word grade appears in none of them.

The pharmacopeia name is the opposite. It is one of the few quality words in this market that a seller cannot use for free.

What an official compendium is, in the statute's own words

Federal law defines the term. An official compendium means the official United States Pharmacopoeia, the official Homoeopathic Pharmacopoeia of the United States, the official National Formulary, or any supplement to any of them.

The same definitions section does something else worth noticing. The first branch of the legal definition of a drug is articles recognized in one of those books. Recognition in the compendium is itself one route to being a drug, before anyone says a word about what the product is for.

The books themselves are published by standards organizations rather than by a regulator. What turns a standard into a consequence is the statute pointing at it, and the statute points at it in three separate places.

Borrowing the name imports the standard

The adulteration section is the first place. A drug is deemed adulterated if it purports to be, or is represented as, a drug whose name is recognized in an official compendium. The condition is that its strength differs from, or its quality or purity falls below, the standard set out in that compendium.

Read the second half of that sentence carefully. The comparison is not made by whatever method the seller chose. The statute says the determination of strength, quality and purity is made using the tests or methods of assay set out in the compendium itself.

So a compendial name does two things at once. It names a standard, and it names the way the standard is measured. A number produced by some other method is not an answer to the question the statute asks.

The escape clause, and how narrow it is

The same section supplies a way out, and the way out is the interesting part.

A drug defined in an official compendium is not adulterated under that paragraph merely because it differs from the compendial standard, if the difference is plainly stated on its label.

A federal regulation then says what plainly stated means. A statement that a compendial drug differs in strength, quality or purity from the compendial standard has to show all the respects in which it differs, and the extent of each difference.

That is a real disclosure duty rather than a disclaimer. Naming every respect and the size of each gap is harder than meeting the standard would have been, which is presumably the point.

The packaging half of the same rule

The misbranding section is the second place the statute points at the books.

A drug is misbranded if it purports to be a drug whose name is recognized in an official compendium, unless it is packaged and labeled as prescribed in that compendium.

This one catches the container and the printed matter rather than the contents. A preparation can be exactly what it claims chemically and still fail here, because the compendium describes how such a drug is supposed to be presented.

The two rules work as a pair. One is about what is inside, the other is about what is on the outside, and both are triggered by the same act of using the name.

You cannot take the name without taking the identity

The third place is a regulation on drug names, and it closes the obvious loophole.

The name a drug is designated by has to be clearly distinguishing and differentiating from any name recognized in an official compendium. The exception is a drug that complies in identity with the identity the compendium prescribes under that name. The same regulation defines a compendially defined drug as one having exactly that identity.

A related regulation explains why so many familiar labels end in those three letters. Where no official name has been designated and the article is recognized in an official compendium, the established name of the drug is the compendium's own official title for it.

An approved product familiar to anyone who has reconstituted a vial shows it. The label of Bacteriostatic Water for Injection, USP carries those three letters as part of the name itself. They are not decoration and they are not a grade. They are the compendial title, and using them is a claim of compendial identity.

The clause that catches everything else

Most of what this market sells has no compendial name to borrow. There is a separate clause for that, and on these pages it is the one that matters most.

A drug not covered by the compendial paragraph is adulterated if its strength differs from, or its purity or quality falls below, that which it purports or is represented to possess.

Nothing in that sentence requires an outside standard. The seller's own representation becomes the measuring stick. A purity figure printed on a listing, a potency stated on a label, a promise about what a container holds: each one sets a level the article then has to reach.

The practical reading is direct. A specific claim is a commitment, and a vague one is not. Pharmaceutical grade commits a seller to nothing because it states nothing, which is exactly why it appears so often.

Where a compendial standard already bites in compounding

One more place is worth knowing about, and it is covered in full elsewhere here.

The federal compounding provision conditions its exemptions on the starting material. A bulk substance qualifies where it complies with an applicable pharmacopeial or formulary standard, or is a component of an approved drug product, or appears on a list the agency maintains. How those three doors work, and which one most peptides have to try, is the subject of the article on the bulk substances lists.

The point to carry away is only this. A compendial standard is doing work in this market already, at the level of the raw material and as a condition on a pharmacy. That is a different thing from a grade word on a product page.

Reading a quality phrase in about a minute

Ask what the phrase would have to be true of. Pharmaceutical grade, research grade and medical grade do not name a standard, a test or a body that publishes either.

Look for a compendial title rather than a grade word. A name that matches a pharmacopeia's own title is a checkable claim, because the statute says what that name imports.

Look for the method beside the number. Where a compendial name is used, the statute expects the compendium's own tests, so a result with no method stated cannot be compared to the standard being invoked.

Treat a specific number as the seller's own standard. Under the clause for products with no compendial name, a stated purity or potency is the level the article is measured against.

Notice where a chapter number is being used as a badge. A chapter is a procedure, and citing its number is not the same as publishing what the procedure returned.

Sources

Each document below is named as it names itself, with the date printed on that document rather than the day it was read.

1. Title 21 United States Code section 321, Definitions; generally, including subsection (j) defining an official compendium and subsection (g)(1)(A) making articles recognized in those books drugs — Office of the Law Revision Counsel, U.S. House of Representatives, September 2026
2. Title 21 United States Code section 351, Adulterated drugs and devices, subsection (b) on strength, quality or purity differing from an official compendium and subsection (c) on misrepresentation where a drug is unrecognized in a compendium — Office of the Law Revision Counsel, U.S. House of Representatives, September 2026
3. Title 21 United States Code section 352, Misbranded drugs and devices, subsection (g) requiring a drug that purports to carry a compendially recognized name to be packaged and labeled as the compendium prescribes — Office of the Law Revision Counsel, U.S. House of Representatives, September 2026
4. 21 CFR 299.5, Drugs; compendial name, requiring a drug's name to be clearly distinguishing from a compendial name unless it complies in identity, and requiring a statement of difference to show all respects and the extent of each — Office of the Federal Register, Electronic Code of Federal Regulations, September 2026
5. 21 CFR 299.4, Established names for drugs, providing that where no official name has been designated the established name of a compendially recognized article is the compendium's official title — Office of the Federal Register, Electronic Code of Federal Regulations, September 2026
6. Bacteriostatic Water for Injection, USP — FDA-approved prescribing information, whose established name carries the compendial title — National Library of Medicine, DailyMed, May 2026